Could a sleep drug lift depression? new trial seeks answers

NCT ID NCT07573176

Recruiting now Symptom relief Sponsor: Janssen Research & Development, LLC Source: ClinicalTrials.gov ↗

First seen May 14, 2026 · Last updated May 14, 2026

Summary

This study tests whether seltorexant, a drug that targets sleep, can improve depressive symptoms in 600 adults with major depression and insomnia. Participants receive either the drug or a placebo for several weeks, then all may receive the drug long-term. The goal is to see if treating sleep problems can ease depression.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEPRESSIVE DISORDER, MAJOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Accelerated Clinical Research Group LLC
RECRUITING

Snellville, Georgia, 30078, United States
Northwest Clinical Research Center
RECRUITING

Bellevue, Washington, 98007, United States
Nuovida Research Center
RECRUITING

Miami, Florida, 33186, United States
Patient Priority Clinical Sites LLC
RECRUITING

Cincinnati, Ohio, 45215, United States
UHC Research
RECRUITING

Doral, Florida, 33178, United States

Conditions

Explore the condition pages connected to this study.

DEPRESSIVE DISORDER, MAJOR